Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 45 páginas
Examen

WGU D027 Advanced Pathopharmacological Foundations Final Exam – Comprehensive OA Practice 2026/2027 Edition

Document preview thumbnail
Vista previa 4 fuera de 45 páginas

This document provides a comprehensive practice resource for the WGU D027 Advanced Pathopharmacological Foundations final assessment, designed to help students review advanced concepts in disease processes and pharmacologic management. It covers essential topics including cellular injury, inflammation, immune responses, cardiovascular and respiratory disorders, endocrine and renal conditions, neurological disorders, and pharmacological principles. The practice material is designed to reinforce pathopharmacology concepts, support self-assessment, and improve overall assessment readiness.

Vista previa del contenido

WGU D027 ADVANCED
PATHOPHARMACOLOGICAL FOUNDATIONS FINAL
EXAM

COMPREHENSIVE OA PRACTICE (2026/2027 EDITION)




200 Multiple-Choice Questions - Complete OA Practice




Independent-Study Disclaimer
This practice examination is an independent study aid and is not affiliated with, endorsed by, or sponsored by
Western Governors University (WGU) or any other institution. It is provided for educational and self-assessment
purposes only and is not a substitute for official WGU D027 course materials, assessments, or professional
guidance. Standards and evidence are subject to change; always consult current course materials, guidelines,
and clinical references.

, Section 1: Cellular & Genetic Foundations – Adaptation, Injury, Genetics,
Neoplasia, Fluid/Electrolytes (30 questions)
Q1: Which type of cellular adaptation involves a decrease in cell size?
A. Hypertrophy
B. Hyperplasia
C. Metaplasia
D. Atrophy [CORRECT]
Correct Answer: D
Rationale: Atrophy is a decrease in cell size. Hypertrophy increases size, hyperplasia increases number,
and metaplasia is a change in cell type.

Q2: Which type of cellular adaptation involves an increase in cell size?
A. Atrophy
B. Metaplasia
C. Hypertrophy [CORRECT]
D. Dysplasia
Correct Answer: C
Rationale: Hypertrophy is an increase in cell size. Atrophy decreases size, and the others differ.

Q3: Which type of cellular adaptation involves an increase in the number of cells?
A. Hyperplasia [CORRECT]
B. Hypertrophy
C. Atrophy
D. Metaplasia
Correct Answer: A
Rationale: Hyperplasia is an increase in cell number. The others are different adaptations.

Q4: Which type of cellular adaptation is a reversible change in which one adult cell type is replaced by another?
A. Dysplasia
B. Metaplasia [CORRECT]
C. Atrophy
D. Hyperplasia
Correct Answer: B
Rationale: Metaplasia is the replacement of one adult cell type by another. Dysplasia is disordered growth,
and the others differ.

Q5: Which of the following is a disorderly, often pre-neoplastic cell growth?
A. Metaplasia
B. Dysplasia [CORRECT]
C. Hyperplasia
D. Atrophy
Correct Answer: B
Rationale: Dysplasia is disordered growth, often pre-neoplastic. The others are different adaptations.



WGU D027 Advanced Pathopharmacological Foundations - 2026/2027 Edition Page 2

, Q6: Which type of necrosis is most typical of ischemic cell death (e.g., in a myocardial infarction)?
A. Liquefactive necrosis
B. Coagulative necrosis [CORRECT]
C. Caseous necrosis
D. Fat necrosis
Correct Answer: B
Rationale: Coagulative necrosis is typical of ischemia (e.g., MI). Liquefactive occurs in the brain, caseous in
TB, and fat necrosis in fatty tissue.

Q7: Which type of necrosis is characteristic of a tuberculous infection?
A. Coagulative necrosis
B. Caseous necrosis [CORRECT]
C. Liquefactive necrosis
D. Fat necrosis
Correct Answer: B
Rationale: Caseous necrosis is characteristic of TB. The others are different types of necrosis.

Q8: Which type of necrosis is most typical of the brain?
A. Coagulative necrosis
B. Caseous necrosis
C. Fibrinoid necrosis
D. Liquefactive necrosis [CORRECT]
Correct Answer: D
Rationale: The brain undergoes liquefactive necrosis. Coagulative is typical of other organs. The others
differ.

Q9: Which of the following is programmed cell death that is energy-dependent and does not typically trigger
inflammation?
A. Necrosis
B. Gangrene
C. Caseation
D. Apoptosis [CORRECT]
Correct Answer: D
Rationale: Apoptosis is programmed, energy-dependent cell death without inflammation. Necrosis triggers
inflammation. The others differ.

Q10: Which of the following is TRUE about necrosis?
A. It is programmed cell death
B. It is unregulated cell death that triggers an inflammatory response [CORRECT]
C. It is always benign
D. It does not cause inflammation
Correct Answer: B
Rationale: Necrosis is unregulated cell death with inflammation. Apoptosis is programmed. The others are
incorrect.




WGU D027 Advanced Pathopharmacological Foundations - 2026/2027 Edition Page 3

, Q11: Which of the following is the hallmark of acute inflammation?
A. Neutrophil infiltration and edema [CORRECT]
B. Lymphocyte infiltration and fibrosis
C. Granuloma formation
D. Scar tissue
Correct Answer: A
Rationale: Acute inflammation features neutrophils and edema. Chronic inflammation features lymphocytes,
granulomas, and fibrosis.

Q12: Which of the following is a mediator of the immune response?
A. Cytokines, interleukins, and chemokines [CORRECT]
B. Only glucose
C. Only electrolytes
D. Only oxygen
Correct Answer: A
Rationale: Cytokines, interleukins, and chemokines are immune mediators. The others are not.

Q13: Which of the following is TRUE about the role of genetics in disease?
A. Genetics has no role
B. All diseases are purely genetic
C. Genetic variations can influence disease risk and drug metabolism (pharmacogenomics) [CORRECT]
D. Genetics only affects appearance
Correct Answer: C
Rationale: Genetic variations influence disease risk and drug metabolism. The others are incorrect.

Q14: Which of the following is an example of pharmacogenomics?
A. Giving the same dose to everyone
B. Ignoring genetics
C. Using CYP2D6 genotype to guide drug selection/dosing [CORRECT]
D. Using age alone for dosing
Correct Answer: C
Rationale: Pharmacogenomics uses genetic variants (e.g., CYP2D6) to guide therapy. The others are
incorrect.

Q15: Which enzyme is commonly involved in pharmacogenomic drug metabolism?
A. CYP2D6 (and other CYP enzymes) [CORRECT]
B. Amylase
C. Trypsin
D. Pepsin
Correct Answer: A
Rationale: CYP enzymes, especially CYP2D6, are key in drug metabolism. The others are digestive
enzymes.




WGU D027 Advanced Pathopharmacological Foundations - 2026/2027 Edition Page 4

Información del documento

Subido en
17 de agosto de 2026
Número de páginas
45
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$14.49

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Vendido
3
Seguidores
0
Artículos
161
Última venta
4 días hace



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes